Alternatives to Cognito Therapeutics

OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.

Global network of clinics using AI and data science to treat age-related cognitive and functional decline.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

Sinaptica Therapeutics is a biotechnology company developing novel therapies for neurodegenerative diseases, focusing on synaptic dysfunction.

AI-powered platform for early Alzheimer's detection and personalized care.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing advanced vision restoration technology through a retinal implant.

Developing lightweight bionic technology.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Developing soft, stretchable brain-computer interface platforms.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Developing novel male contraceptives.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and distributes bioreactor technology for stem cell cultivation.

Elevating uterine health through innovative biomaterial therapies.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

Developing breath-based diagnostics for lung diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.